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Background: The survival rate of lung cancer is related to the staging 
of the disease at diagnosis, thus to diagnose lung cancer at a stage 
that curative treatment can be applied might improve the survival rate 
of lung cancer. While the detection of early lung cancer is difﬁcult 
in smokers without silicosis, the detection of lung cancer in silicosis 
subjects is even more difﬁcult as most of these subjects have radiologi-
cal abnormalities. Autoﬂuorescence bronchoscopy has been found to 
be useful in the localization of sputum cytology positive, radiological 
occult lung cancer. Yet its role in detecting lung cancer among smokers 
with silicosis has not been evaluated.
Study Objectives: To evaluate the efﬁcacy of combining sputum cytol-
ogy and autoﬂuorescence bronchoscopy in detecting early lung cancer 
in smokers with silicosis
Methods: Early morning sputum for 2 consecutive days is being col-
lected from eligible subjects (age 40 or above, accumulated 20-pack 
year smoking history and silicosis followed up at Pneumoconiosis 
Clinic) for cytological examination. Subjects with sputum cytology 
abnormality (atypical, suspicious or carcinoma cells) are invited to 
undergo bronchoscopic examination (white light followed by autoﬂuo-
rescence bronchoscopy). 
Results: Upto now, 21 subjects showed atypical cells in sputum and 
19 have undergone bronchoscopic examination. The mean age and 
smoking history were 69.63±9.65 years and 56.03±41.58 pack years 
respectively. One subject was found to have carcinoma-in-situ and 
another subject was found to have dysplastic lesions.
Conclusion: Sputum examination followed by autoﬂuorescence 
bronchoscopy seems to be useful in early detection of lung cancer in 
smokers with silicosis.
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Background: Autoﬂuorescence bronchoscopy has been shown to be 
more sensitive than conventional bronchoscopy to detect early mucosal 
lesions in the central airways. However increased sensitivity leads to 
excessive biopsy, increased procedural time, and compromised patient 
safety. Onco-LIFE (Xilix Technologies Corp; BC, Canada), a device 
that combines ﬂuorescence and reﬂectance imaging, aims at reducing 
false-positive ﬂuorescence due to increased vascularity associated with 
inﬂammation since red light is less absorbed by haemoglobin. It also 
allows numeric representation in the central portion of the image by 
expressing red to green ratio (R/G ratio) of the lesion of interest.
Aim: To determine if the addition of quantitative image analysis (R/G 
ratio) to autoﬂuorescence bronchoscopy could provide an objective 
means to guide biopsy selectively.
Methods: Subjects at risk for lung cancer were recruited for bronchos-
copy with Onco-LIFE at 2 centers: VUMC in Amsterdam and BCCA 
in Canada. The R/G ratio of each site that appeared normal or abnormal 
was ﬁrst measured in real time prior to taking a biopsy. The specimens 
were scored by a pathology panel according to WHO classiﬁcation. R/
G ratios of moderate dysplasia and worse (high grade dysplasia) were 
compared against low grade dysplasia. Following retrospective analysis 
of the training dataset obtained from 2 centers, a prospective study was 
performed at VUMC for validation. 
Results: A total of 3362 adequate biopsies with corresponding R/G 
ratios were analyzed. Obvious carcinoma was excluded, and for 70 of 
these sites, visual scoring into class I (normal), II (abnormal including 
metaplasia and mild dysplasia) or III (moderate dysplasia and worse) 
was also performed. Fig 1 shows ROC of high grade versus low grade 
dysplasia. The area under the curve was 0.89, and R/G ratio 0.54 gives 
83% sensitivity and 80% speciﬁcity. The RG values also correlated 
well with visual classiﬁcation (r=0.78, p< 0.0001) and histology 
(r=0.64, p<0.0001).
Conclusion: Quantitative image analysis could objectively guide the 
bronchoscopist in selecting optimal sites for biopsy (RG≥0.54) with 
good pathological correlation.
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Background: Head and neck cancer (HNC) is the 5th most common 
cancer worldwide and the most common neoplasm in Asia. Despite 
good locoregional tumor control achieved with current treatment strate-
gies, ﬁeld cancerization predisposes these patients to second primary 
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tumors especially lung cancer which impact outcome. Post-treatment 
surveillance is therefore practiced on the premise that early detection 
and timely treatment of recurrences and second primary lung cancers 
(SPLC) could improve outcome. 
Objectives: To determine the outcome of curatively treated HNC 
patients referred because of the suspicion of SPLC. 
Methods: Between 1996 and 2005, patients with HNC referred for 
respiratory symptoms and/ or radiological abnormalities suspicious for 
lung cancer were evaluated with radiology and autoﬂuorescence bron-
choscopy. Data on patient demographics, smoking, pack years, cancer 
characteristics and outcome were collected and analyzed.
Results: Fifty-one patients (44 males) with curatively treated N0 
HNC were evaluated. Median age was 70 years (range, 63-79), all 
were current or former smokers of 35 pack years (range, 30-45) and 
25 had chronic obstructive lung disease. With a median follow up of 
60 months, 8 patients were diagnosed with synchronous and 26 with 
metachronous SPLC. A total of 42 SPLC were diagnosed; 12 (29%) in 
the central airways and 30 (71%) parenchymal. Median time to meta-
chronous SPLC was 24 months. Most of SPLC (38/42) were surgically 
resectable. Five occult cancers detected by AF bronchoscopy were 
successfully treated with endobronchial therapy. Lung cancer mortal-
ity was 24%. Survival of synchronous and metachronous SPLCs was 
signiﬁcantly shorter (83 and 144 months) compared to those with HNC 
alone (240 months) (p=0.002).
Conclusion: SPLC has a negative impact on the survival of patients 
with HNC. Close surveillance with autoﬂuorescence bronchoscopy and 
CT for SPLC combined with aggressive treatment of early stage lung 
cancer might be a strategy to improve outcome. 
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Background: Harbor Hospital is located in downtown Baltimore, 
serving largely blue-collar workers with very high smoking prevalence. 
Non-small cell lung cancer is the most common malignancy seen at 
this hospital, usually diagnosed at inoperable or metastatic stages. We 
pioneered low-cost and free chest CT scan program for this high risk 
population based on recent data indicating that yearly screening CT 
scans of chest can lead to early lung cancer diagnosis, and may reduce 
the lung cancer mortality.
Methods: Low cost screening chest CT scan was advertised through 
mass media and was offered to general population. We secured outside 
funding for approximately 300 free screening chest CT scans and these 
were offered through local primary care providers who were asked to 
identify individuals at high risk for lung cancer development based 
on their smoking and/or asbestos exposure history. Overall eligibility 
criteria for screening CT scan were age 55 and above, with at least 20 
pack-year smoking history. All CT scans were done at Harbor Hospital 
Radiology Department, and results were classiﬁed as negative, indeter-
minate or suspicious. Indeterminate or suspicious results were reviewed 
and discussed at the multidisciplinary Lung Tumor conference and 
follow-up recommendation was issued according to the Early Lung 
Cancer Action Program (ELCAP) guidelines.
Results: A total of 492 patients underwent screening chest CT scans 
between 3/2003 and 2/2006. Median age of patients was 57 years 
(33-80), with 261(53%) women and 231(47%) men. The majority of 
screened population was Caucasian (68%), with 20% African Ameri-
cans and small number of Asians (3%). More than 95% of the patients 
were current or ex-smokers, with median of 33-pack year smoking 
history (3-200). Among 459 smokers, 133 (29%) were former smokers 
with median of 10-year smoking cessation history (1mo to 40 years). 
Initial CT scan results were reported as normal in 258 (52%) and 
indeterminate in 234(48%). Non-small cell lung cancer was diagnosed 
in 8 patients (1.6%), who were referred to appropriate disciplines for 
staging and treatment. Three out of 8 patients were found to have stage 
I/II NSCLC and underwent surgical resection. Total of 10 out of 492 
patients were diagnosed with cancer, two additional patients were inci-
dentally found with other types of cancers, one laryngeal and another 
with pancreatic cancer. 
Conclusion: Eight cases of NSCLC were diagnosed after screen-
ing 492 high-risk populations at a community hospital in downtown 
Baltimore. Among them, three patients (38%) were found to have early 
stage lung cancer and were offered curative resection. Following our 
experience, many other local community hospitals engaged in similar 
programs to provide low cost chest CT scans for early lung cancer 
detection. In our limited experience, screening chest CT scans yielded 
relatively more early stage lung cancers than our historical control. 
The usefulness of this approach remains to be established with ongo-
ing large multicenter randomized trials sponsored by National Cancer 
Institute and ELCAP. 
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